KA
CL icon

Klingman & Associates’s Colgate-Palmolive CL Stock Holding History

Klingman & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$351K Buy
4,118
+188
+5% +$16.8K 0.02% 240
2025
Q4 		$311K Buy
3,930
+321
+9% +$25.2K 0.02% 249
2025
Q3 		$289K Sell
3,609
-126
-3% -$10.7K 0.01% 259
2025
Q2 		$340K Buy
3,735
+169
+5% +$15.4K 0.02% 229
2025
Q1 		$334K Buy
3,566
+147
+4% +$13.2K 0.02% 208
2024
Q4 		$311K Sell
3,419
-25
-0.7% -$2.39K 0.02% 201
2024
Q3 		$358K Buy
3,444
+32
+0.9% +$3.26K 0.02% 198
2024
Q2 		$331K Buy
3,412
+49
+1% +$4.52K 0.02% 184
2024
Q1 		$303K Hold
3,363
– – 0.02% 192
2023
Q4 		$268K Sell
3,363
-13
-0.4% -$977 0.02% 196
2023
Q3 		$240K Buy
3,376
+435
+15% +$32.5K 0.02% 202
2023
Q2 		$227K Buy
2,941
+45
+2% +$3.48K 0.02% 199
2023
Q1 		$218K Sell
2,896
-110
-4% -$8.18K 0.02% 188
2022
Q4 		$237K Buy
3,006
+2
+0.1% +$150 0.02% 180
2022
Q3 		$211K Buy
3,004
+86
+3% +$6.74K 0.02% 176
2022
Q2 		$234K Buy
2,918
+63
+2% +$4.93K 0.02% 172
2022
Q1 		$216K Buy
2,855
+34
+1% +$2.69K 0.02% 192
2021
Q4 		$241K Buy
+2,821
New +$220K 0.02% 162
2021
Q2 		– Sell
-2,613
Closed -$206K – 164
2021
Q1 		$206K Buy
+2,613
New +$205K 0.02% 162
2016
Q4 		– Sell
-1,670
Closed -$124K – 140
2016
Q3 		$124K Sell
1,670
-341
-17% -$25.2K 0.04% 122
2016
Q2 		$147K Hold
2,011
– – 0.05% 110
2016
Q1 		$142K Hold
2,011
– – 0.05% 113
2015
Q4 		$134K Sell
2,011
-600
-23% -$39.9K 0.05% 137
2015
Q3 		$165K Sell
2,611
-200
-7% -$13.1K 0.06% 124
2015
Q2 		$184K Hold
2,811
– – 0.07% 89
2015
Q1 		$195K Hold
2,811
– – 0.08% 86
2014
Q4 		$194K Buy
+2,811
New +$190K 0.08% 85

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Klingman & Associates's CL Position: Q1 2026 in Review

Klingman & Associates increased its Colgate-Palmolive (CL) stake by 4.8% in Q1 2026, buying an estimated $16.8K and bringing the position to 4,118 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #240.

Klingman & Associates first reported a position in CL in Q4 2014 and has held it in 27 quarters since. The position peaked at $358K in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Klingman & Associates held 4,118 shares of Colgate-Palmolive worth $351K as of Q1 2026.
  • Klingman & Associates bought 188 Colgate-Palmolive shares in Q1 2026, an estimated $16.8K.
  • Colgate-Palmolive made up 0.02% of Klingman & Associates's portfolio in Q1 2026, its #240 holding.
  • Klingman & Associates first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 27 quarters since.
  • Klingman & Associates's Colgate-Palmolive position peaked at $358K in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.